Stock Analysis

Is H&M (OM:HM B) Overvalued After Its Recent Share Price Rebound? A Closer Look at the Valuation

H & M Hennes & Mauritz (OM:HM B) has been quietly rewarding patient shareholders, with the stock gaining about 22% over the past 3 months and roughly 20% year to date.

See our latest analysis for H & M Hennes & Mauritz.

At around SEK 178.65 per share, the 90 day share price return of about 22% and a three year total shareholder return above 80% suggest momentum is clearly building again as investors warm to H & M Hennes & Mauritz’s recovery story.

If H & M’s rebound has you rethinking retail, it could be a good moment to explore auto makers facing their own shifts in demand through auto manufacturers.

Yet with shares trading above analyst targets but still showing a sizable estimated intrinsic discount, the real question is whether H & M remains mispriced value or if the market is already banking on stronger growth ahead.

Most Popular Narrative: 18.5% Overvalued

Compared with the narrative fair value estimate of about SEK 150.74, H & M Hennes & Mauritz’s last close near SEK 178.65 implies investors are already paying up for future margin gains and operational improvements.

Efforts to mitigate external cost pressures, such as negative currency impacts and shipping costs, along with strategic supplier collaborations, are expected to positively affect gross margins and operating profit in the latter half of the year.

Read the complete narrative.

Curious how modest revenue growth, rising margins and a disciplined earnings multiple combine to justify that value gap? Want to see the exact roadmap behind it?

Result: Fair Value of $150.74 (OVERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, persistent cost inflation and weaker sales in key regions could quickly compress margins and challenge the optimism embedded in current expectations.

Find out about the key risks to this H & M Hennes & Mauritz narrative.

Another Angle on Value

Analysts see H & M Hennes & Mauritz as roughly 18.5% overvalued versus a narrative fair value of about SEK 150.74, yet our SWS DCF model points the other way and suggests the shares trade around 53.6% below intrinsic value. Which story do you think the market ultimately prices in?

Look into how the SWS DCF model arrives at its fair value.

HM B Discounted Cash Flow as at Dec 2025
HM B Discounted Cash Flow as at Dec 2025

Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out H & M Hennes & Mauritz for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 904 undervalued stocks based on their cash flows. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.

Build Your Own H & M Hennes & Mauritz Narrative

If you would rather dig into the numbers yourself and shape your own view, you can build a full narrative in just minutes: Do it your way.

A great starting point for your H & M Hennes & Mauritz research is our analysis highlighting 3 key rewards and 1 important warning sign that could impact your investment decision.

Ready for your next investing move?

Before the market shifts again, use the Simply Wall Street Screener to uncover fresh opportunities that match your strategy and keep you a step ahead.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

The New Payments ETF Is Live on NASDAQ:

Money is moving to real-time rails, and a newly listed ETF now gives investors direct exposure. Fast settlement. Institutional custody. Simple access.

Explore how this launch could reshape portfolios

Sponsored Content

Valuation is complex, but we're here to simplify it.

Discover if H & M Hennes & Mauritz might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.

Access Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

About OM:HM B

H & M Hennes & Mauritz

Provides clothing, accessories, footwear, cosmetics, home textiles, and homeware for women, men, and children worldwide.

Flawless balance sheet with proven track record.

Weekly Picks

WO
MGPI logo
woodworthfund on MGP Ingredients ·

THE KINGDOM OF BROWN GOODS: WHY MGPI IS BEING CRUSHED BY INVENTORY & PRIMED FOR RESURRECTION

Fair Value:US$4034.1% undervalued
22 users have followed this narrative
2 users have commented on this narrative
5 users have liked this narrative
DO
Double_Bubbler
EVTL logo
Double_Bubbler on Vertical Aerospace ·

Why Vertical Aerospace (NYSE: EVTL) is Worth Possibly Over 13x its Current Price

Fair Value:US$6089.9% undervalued
22 users have followed this narrative
3 users have commented on this narrative
17 users have liked this narrative
TI
TickerTickle
ORCL logo
TickerTickle on Oracle ·

The Quiet Giant That Became AI’s Power Grid

Fair Value:US$389.8149.0% undervalued
43 users have followed this narrative
4 users have commented on this narrative
8 users have liked this narrative

Updated Narratives

AG
Agricola
EXN logo
Agricola on Excellon Resources ·

A case for CA$31.80 (undiluted), aka 8,616% upside from CA$0.37 (an 86 bagger!).

Fair Value:CA$31.898.8% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
ST
stuart_roberts
UNCY logo
stuart_roberts on Unicycive Therapeutics ·

Unicycive Therapeutics (Nasdaq: UNCY) – Preparing for a Second Shot at Bringing a New Kidney Treatment to Market (TEST)

Fair Value:US$21.5370.2% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
KI
RKLB logo
KiwiInvest on Rocket Lab ·

Rocket Lab USA Will Ignite a 30% Revenue Growth Journey

Fair Value:US$97.8335.1% undervalued
136 users have followed this narrative
8 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

TH
TheWallstreetKing
MVIS logo
TheWallstreetKing on MicroVision ·

MicroVision will explode future revenue by 380.37% with a vision towards success

Fair Value:US$6098.4% undervalued
120 users have followed this narrative
11 users have commented on this narrative
22 users have liked this narrative
AN
AnalystConsensusTarget
NVDA logo
AnalystConsensusTarget on NVIDIA ·

NVDA: Expanding AI Demand Will Drive Major Data Center Investments Through 2026

Fair Value:US$250.3927.7% undervalued
963 users have followed this narrative
6 users have commented on this narrative
25 users have liked this narrative
RO
RockeTeller
SCZ logo
RockeTeller on Santacruz Silver Mining ·

Crazy Undervalued 42 Baggers Silver Play (Active & Running Mine)

Fair Value:CA$8688.0% undervalued
78 users have followed this narrative
8 users have commented on this narrative
21 users have liked this narrative